CompletedPhase 2NCT00990314
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Studying Drug- or toxin-induced pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lung Biotechnology PBC
- Principal Investigator
- Aimee SmartStudy Sponsor
- Intervention
- Beraprost Sodium Modified Release(drug)
- Enrollment
- 31 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2009 – 2013
Study locations (17)
- Harbor-UCLA Medical Center, Torrance, California, United States
- Midwest Heart Foundation - Advocate Medical Group, Oakbrook Terrace, Illinois, United States
- Beth Israel Medical Center, New York, New York, United States
- Albert Einstein College of Medicine, The Bronx, New York, United States
- Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
- UT Southwestern Medical Center, Dallas, Texas, United States
- Universite Libre de Bruxelles, Brussels, Belgium
- Catholic University of Leuven, Leuven, Belgium
- General Teaching Hospital, Prague, Czechia
- Klinikum der Universitat zu Koln, Cologne, Germany
- Medizinische Klinik und Poliklinik, Dresden, Germany
- Abt Innere Medizin III, Medizinische Universitatsklinik, Heidelberg, Germany
- Universitatsklinik Leipzig Abteilung Pulmologie, Leipzig, Germany
- Mater Misericordiae University Hospital Ltd., Dublin, Ireland
- Institutul de Urgenta pentru Boli, Bucharest, Romania
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00990314 on ClinicalTrials.govOther trials for Drug- or toxin-induced pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07529821Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Treadmill Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Pre-hypertensive PatientsFoundation University Islamabad
- ACTIVE NOT RECRUITINGNCT07312227A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in BoliviaMassachusetts General Hospital
- ENROLLING BY INVITATIONNANCT07558460Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled TrialIstanbul University - Cerrahpasa
- RECRUITINGPHASE2NCT07318597Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)Regeneron Pharmaceuticals
- RECRUITINGPHASE1NCT06872112A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial HypertensionJoseph C. Wu
- RECRUITINGPHASE2NCT06351345129 Xenon Imaging in Patients Treated With SotaterceptBastiaan Driehuys
- RECRUITINGPHASE4NCT07140484Sotatercept in Pulmonary Arterial HypertensionUniversity of Alberta
- RECRUITINGPHASE2NCT07175038A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)AllRock Bio, Inc.
See all trials for Drug- or toxin-induced pulmonary arterial hypertension →